Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

divaza

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
AIM To investigate the efficacy of divaza in outpatients with cognitive disorders and chronic brain ischemia (CBI). MATERIAL… Expand
2017
2017
AIM To study the efficacy and safety of divasa in elderly and senile subjects with asthenic and mild to moderate cognitive… Expand
2017
2017
AIM To evaluate the efficacy and safety of divazа in the treatment of cognitive and emotional disorders in patients with chronic… Expand
Review
2017
Review
2017
The article presents the data of studies of nitric oxide (NO) in the pathogenesis of cerebrovascular diseases. It is emphasized… Expand
2016
2016
AIM On amnesia models induced by (icv) injection of β-amyloid fragment 25-35 peptide were evaluated antiamnestic actitity… Expand
2016
2016
AIM To evaluate the efficacy of the drug divasa in treatment of cognitive and emotional disorders in patients in the early… Expand
2015
2015
The anxiolytic and antidepressant activities of complex preparations divaza and brizantin containing antibodies to brain-specific… Expand
  • table 1
  • table 2
  • table 3
Review
2014
Review
2014
: The present paper reviews preclinical research of divaza, the combination of release-active antibodies to brain-specific 5100… Expand
Review
2014
Review
2014
The present paper reviews preclinical research of divaza, the combination of release-active antibodies to brain-specific 5100… Expand
Review
2012